FDA Approves, Leqembi, New Treatment for Early Alzheimer’s

on January 06, 2023 0 Comment
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.

from NYT > Business https://ift.tt/VHb3sMW
https://ift.tt/Qo4yVPx

SHARE THIS
Web series

Author:

Etiam at libero iaculis, mollis justo non, blandit augue. Vestibulum sit amet sodales est, a lacinia ex. Suspendisse vel enim sagittis, volutpat sem eget, condimentum sem.

0 $type={blogger}: